ALK and neuroblastoma: To inhibit MYCN expression completely and to further clarify the extent to which it contributes to mTORC1 activity in the presence of mutated ALK, we overexpressed ALKF1174L in the SHEP NB cell line, which stably expresses a tetracycline-repressible MYCN construct (Fig. 2B).